Olivier Kosmider

25PUBLICATIONS
240CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 15, 2026
The First Reported Case of VEXAS Syndrome in Lebanon: Efficacy of Azacitidine as a Therapeutic Option-Case Report.

|Mar 02, 2026
Inflammatory cell death and monocyte dysfunction in VEXAS syndrome.

Paul Breillat, Samuel J Magaziner, Stéphane M Camus

|Jan 16, 2026
Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndrome.

Lin-Pierre Zhao, Olivier Kosmider, Maël Heiblig

|Dec 17, 2025
Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia.

Elissa Khadra, Zoaila Iqbal, Morgane Le Gall

|Sep 19, 2025
VEXAS anemia is a mosaic erythroblastopenia.

Francois Rodrigues, Giulia Hardouin, Sara El Hoss

|Jul 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Paul Breillat, Francesco Carbone, Emilie Lereclus

Pageof 5

Frequent Collaborators

6 joint publications

Marie Templé

5 joint publications

Lionel Adès

5 joint publications

Jérôme Tamburini

5 joint publications

Nicolas Chapuis